Dana Investment Advisors’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.72M Buy
29,919
+2,093
+8% +$522K 0.2% 129
2025
Q4
$6.7M Buy
27,826
+1,102
+4% +$282K 0.2% 123
2025
Q3
$7.32M Sell
26,724
-4,272
-14% -$1.17M 0.21% 110
2025
Q2
$8M Sell
30,996
-1,612
-5% -$385K 0.26% 91
2025
Q1
$7.3M Buy
32,608
+3,355
+11% +$783K 0.26% 94
2024
Q4
$6.69M Buy
29,253
+303
+1% +$73K 0.22% 121
2024
Q3
$7.07M Buy
28,950
+4,249
+17% +$949K 0.23% 117
2024
Q2
$4.73M Buy
+24,701
New +$5.01M 0.16% 170
2022
Q2
Sell
-1,296
Closed -$314K 436
2022
Q1
$314K Hold
1,296
0.01% 307
2021
Q4
$338K Hold
1,296
0.01% 288
2021
Q3
$342K Hold
1,296
0.02% 276
2021
Q2
$319K Hold
1,296
0.01% 281
2021
Q1
$251K Sell
1,296
-297
-19% -$59.6K 0.01% 303
2020
Q4
$339K Buy
1,593
+29
+2% +$5.78K 0.02% 259
2020
Q3
$268K Buy
1,564
+7
+0.4% +$1.29K 0.01% 255
2020
Q2
$299K Sell
1,557
-390
-20% -$63.8K 0.02% 242
2020
Q1
$287K Sell
1,947
-25,474
-93% -$4.06M 0.02% 241
2019
Q4
$4.25M Buy
27,421
+4,651
+20% +$670K 0.2% 79
2019
Q3
$3.08M Buy
+22,770
New +$2.98M 0.16% 89

Other funds holding RMD

Dana Investment Advisors's RMD Position: Q1 2026 in Review

Dana Investment Advisors increased its ResMed (RMD) stake by 7.5% in Q1 2026, buying an estimated $522K and bringing the position to 29,919 shares worth $6.72M. The position accounts for 0.2% of the portfolio, ranked #129.

Dana Investment Advisors first reported a position in RMD in Q3 2019 and has held it in 19 quarters since. The position peaked at $8M in Q2 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Dana Investment Advisors held 29,919 shares of ResMed worth $6.72M as of Q1 2026.
  • Dana Investment Advisors bought 2,093 ResMed shares in Q1 2026, an estimated $522K.
  • ResMed made up 0.2% of Dana Investment Advisors's portfolio in Q1 2026, its #129 holding.
  • Dana Investment Advisors first reported a position in ResMed in Q3 2019 and has held it in 19 quarters since.
  • Dana Investment Advisors's ResMed position peaked at $8M in Q2 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Dana Investment Advisors's 13F filing for Q1 2026, filed 14 May 2026.